Merck (MRK): Rep. Jared Moskowitz (FL23) disclosed a purchase $1K–$15K
Rep. Jared Moskowitz (FL23) disclosed a purchase of Merck in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 25 days
- Disclosure lag
- Traded
- Dec 28, 2023
- Disclosed
- Jan 22, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 26, 2023CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
- Oct 16, 2023CongressDisclosed sale of MRK — reported range $1,001 - $15,000
- Oct 24, 2023CongressDisclosed sale of MRK — reported range $1,001 - $15,000
- Oct 31, 2023FDAFDA drug approval: Keytruda
- Oct 31, 2023FDAFDA drug approval: Keytruda
- Nov 7, 2023FDAFDA drug approval: Keytruda
- Nov 16, 2023FDAFDA drug approval: Keytruda
- Dec 14, 2023FDAFDA drug approval: Welireg
- Dec 15, 2023FDAFDA drug approval: Keytruda
- Dec 15, 2023FDAFDA drug approval: Keytruda
- Dec 28, 2023 · this disclosureCongressDisclosed purchase of MRK — reported range $1,001 - $15,000
What came next
- Dec 28, 2023CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
- Jan 12, 2024FDAFDA drug approval: Keytruda
- Jan 23, 2024Congress · 1 personMembers of Congress: 3 purchases
- Jan 25, 2024FDAFDA drug approval: Keytruda
- Mar 26, 2024FDAFDA drug approval: Winrevair
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Merck
For Merck, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 4 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.
Other recent filings by Rep. Jared Moskowitz (FL23)
- House Clerk periodic transaction report at Applied Materials (AMAT)Aug 27, 2026
- House Clerk periodic transaction report at Steris (STE)Aug 27, 2026
- House Clerk periodic transaction report at W. W. Grainger (GWW)Aug 27, 2026
- House Clerk periodic transaction report at S&P Global (SPGI)Jul 26, 2026
- House Clerk periodic transaction report at Applied Materials (AMAT)Jul 26, 2026
The full history of Rep. Jared Moskowitz (FL23) is on the profile page.
How this filing works
Explore the data
Other disclosures at Merck
- SEC Form 144Nov 12, 2026
- SEC Form 144Nov 2, 2026
- House Clerk periodic transaction reportOct 7, 2026
- USAspending.gov award recordSep 24, 2026
- USAspending.gov award recordSep 17, 2026
- House Clerk periodic transaction reportSep 9, 2026
Everything OQRO holds on this company is on its MRK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
